Attention www.globalkeysolutions.net is now www.keypedia.com, read the full press release here.
KeyPedia LogoKeyPedia Icon
  1. Home
  2. /
  3. Records
  4. /
  5. Warning Letter
  6. /
  7. Hospira Inc.
WARNING LETTER
•Hospira Inc.•February 7, 2013

Hospira Inc. – FDA Warning Letter, Feb 7, 2013

Record Details

The FDA issued a Warning Letter to Hospira, Inc. following an inspection from January 29 to February 7, 2013, which identified significant violations of the Quality System (QS) Regulation for medical devices. The inspected devices included Class II infusion systems: GemStar, Plum A+, LifeCare PCA, and Symbiq. These devices were deemed adulterated due to non-conformity with current Good Manufacturing Practice (CGMP) requirements (21 CFR Part 820).

Key violations include: - **Design Controls (21 CFR 820.30):** Failure to establish adequate procedures for design requirements (e.g., Plum A+ battery specifications), design verification (battery life expectancy), design validation (risk analysis for GemStar overdose issue), and updating design and development plans (GemStar Rollback project). Hospira's responses were deemed inadequate, lacking interim actions for in-market Plum A+ pumps and sufficient documentation. - **Corrective and Preventive Action (CAPA) (21 CFR 820.100):** Inadequate CAPA system implementation, including failure to trend component failures (Plum A+ APP board, San Jose repair site data), implement identified corrective actions for battery failures (CAPA 200900000000000000000000000000000000

Company
Hospira Inc.
Inspection date
February 7, 2013
Product type
Devices
Office
Chicago District Office
People
  • Scott J. Macintire
  • Zena G. Kaufman
  • Brian J. Smith
View Company Profile

ID · 282a1745-3715-4bad-9609-1e348117644b

Violation Codes10
21 U.S.C. 321(h)21 U.S.C. 351(h)21 CFR 82021 CFR 820.30(c)21 CFR 820.30(f)21 CFR 820.30(g)21 CFR 820.30(b)21 CFR 820.100(a)21 CFR 820.100(a)(1)21 CFR 820.100(a)(4)

Full citation text and observation details available on the Dashboard.

Other documents for Hospira Inc.
  • EIR - 2016-07-14July 14, 2016
  • 483 - 2013-02-07February 7, 2013
  • 483 - 2012-07-13July 13, 2012

Your cart

Your cart is empty.

Browse public document pages and click Buy this document. We'll ask for your email at checkout, no account needed up front.

Browse documents

Discuss this record with AI

KeyPedia

ChatGPT

Claude

Perplexity

Grok

Copilot

Document or profile

One record shows the event. A profile shows the pattern.

Buy this document for the source file and details behind this single event.

Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.

Explore Hospira Inc.
KeyPedia
Regulatory Data Transformed
Stay in the loop

KRA score changes, company updates and news. About monthly, unsubscribe anytime.

Contact
New York Office:
370 Jay Street 7th Floor
Brooklyn, NY 11201
Scranton Office:
Scranton Enterprise Center, Suite 217
201 Lackawanna Avenue
Scranton, PA, 18503
🇺🇸+1 917-789-5099
🇪🇺+48 532-447-507
info@keypedia.com
Quick Links
HomePlatform OverviewMedia
KeyPedia™ Lite
Browse HubDatabase DirectoryRecordsCompaniesOfficesPeopleCareersAbout UsFounding TeamMeet Our ExpertsPartners
Legal & Ethics
Privacy PolicyTerms of ServiceOur Values & MissionCode of Ethics & AI Policy
©2026 KeyPedia™ | Global Key Solutions Corp. All rights reserved.